Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-04-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Online Access: | https://doi.org/10.1186/s13023-024-03110-3 |
| _version_ | 1797219595888623616 |
|---|---|
| author | Shahram Attarian Peter Young Thomas H. Brannagan David Adams Philip Van Damme Florian P. Thomas Carlos Casanovas Jafar Kafaie Céline Tard Maggie C. Walter Yann Péréon David Walk Amro Stino Marianne de Visser Camiel Verhamme Anthony Amato Gregory Carter Laurent Magy Jeffrey M. Statland Kevin Felice |
| author_facet | Shahram Attarian Peter Young Thomas H. Brannagan David Adams Philip Van Damme Florian P. Thomas Carlos Casanovas Jafar Kafaie Céline Tard Maggie C. Walter Yann Péréon David Walk Amro Stino Marianne de Visser Camiel Verhamme Anthony Amato Gregory Carter Laurent Magy Jeffrey M. Statland Kevin Felice |
| author_sort | Shahram Attarian |
| collection | DOAJ |
| first_indexed | 2024-04-24T12:36:09Z |
| format | Article |
| id | doaj.art-667ec559a27c41e486ae7d0fb0dca401 |
| institution | Directory Open Access Journal |
| issn | 1750-1172 |
| language | English |
| last_indexed | 2024-04-24T12:36:09Z |
| publishDate | 2024-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Orphanet Journal of Rare Diseases |
| spelling | doaj.art-667ec559a27c41e486ae7d0fb0dca4012024-04-07T11:30:37ZengBMCOrphanet Journal of Rare Diseases1750-11722024-04-011911210.1186/s13023-024-03110-3Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1AShahram Attarian0Peter Young1Thomas H. Brannagan2David Adams3Philip Van Damme4Florian P. Thomas5Carlos Casanovas6Jafar Kafaie7Céline Tard8Maggie C. Walter9Yann Péréon10David Walk11Amro Stino12Marianne de Visser13Camiel Verhamme14Anthony Amato15Gregory Carter16Laurent Magy17Jeffrey M. Statland18Kevin Felice19Reference Center for Neuromuscular Disorders and ALS, CHU La TimoneDepartment of NeurologyColumbia University Medical Center, The Neurological InstituteFrench Reference Center for Rare Peripheral Neuropathies, Service de Neurologie Adulte, APHP, CHU BicêtreDepartment of Neurology, University Hospitals Leuven, KUDepartment of Neurology, Hackensack University Medical CenterNeuromuscular Unit, Neurology Department, Bellvitge University HospitalDepartment of Neurology, Saint Louis University School of MedicineU1171, Centre de référence des maladies neuromusculaires Nord Est Ile de France, Hôpital Salengro CHU de LilleDepartment of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of MunichCentre de Référence Maladies Neuromusculaires AOCClinical Neuroscience Research Unit, University of MinnesotaUniversity of Michigan Health SystemDepartment of Neurology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam NeuroscienceDepartment of Neurology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam NeuroscienceDepartment of Neurology, Brigham and Women’s HospitalSt. Luke’s Rehabilitation Institute, Physical Medicine and RehabilitationCHU DupuytrenUniversity of Kansas Medical CenterDepartment of Neuromuscular Medicine, Hospital for Special Carehttps://doi.org/10.1186/s13023-024-03110-3 |
| spellingShingle | Shahram Attarian Peter Young Thomas H. Brannagan David Adams Philip Van Damme Florian P. Thomas Carlos Casanovas Jafar Kafaie Céline Tard Maggie C. Walter Yann Péréon David Walk Amro Stino Marianne de Visser Camiel Verhamme Anthony Amato Gregory Carter Laurent Magy Jeffrey M. Statland Kevin Felice Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A Orphanet Journal of Rare Diseases |
| title | Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A |
| title_full | Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A |
| title_fullStr | Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A |
| title_full_unstemmed | Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A |
| title_short | Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A |
| title_sort | correction to a double blind placebo controlled randomized trial of pxt3003 for the treatment of charcot marie tooth type 1a |
| url | https://doi.org/10.1186/s13023-024-03110-3 |
| work_keys_str_mv | AT shahramattarian correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT peteryoung correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT thomashbrannagan correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT davidadams correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT philipvandamme correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT florianpthomas correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT carloscasanovas correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT jafarkafaie correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT celinetard correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT maggiecwalter correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT yannpereon correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT davidwalk correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT amrostino correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT mariannedevisser correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT camielverhamme correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT anthonyamato correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT gregorycarter correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT laurentmagy correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT jeffreymstatland correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a AT kevinfelice correctiontoadoubleblindplacebocontrolledrandomizedtrialofpxt3003forthetreatmentofcharcotmarietoothtype1a |